Revvity, Inc.
NYSE-RVTY
Dec '14
Jan '17
Dec '18
Jan '21
Jan '23
Dec '24
| Revenue | LTM | Dec '24 |
|---|---|---|
Discovery & Analytical Solutions Product Revenue (Pre-Q3 2022) | — | — |
Discovery & Analytical Solutions Service Revenue (Pre-Q3 2022) | — | — |
Total Discovery & Analytical Solutions Revenue (Pre-Q3 2022) | — | — |
Total Diagnostics Revenue (Pre-Q3 2022) | 1,427.9 | 1,500.9 |
Other Revenue | 1,385.5 | 1,254.1 |
Total Revenue | 2,813.4 | 2,755 |
| Revenue | LTM | Dec '24 |
|---|---|---|
Total Discovery & Analytical Solutions Revenue (Post-Q2 2022) | 1,385.5 | 1,254.1 |
Diagnostics Product Revenue (Pre-Q3 2022) | — | — |
Diagnostics Service Revenue (Pre-Q3 2022) | — | — |
Total Diagnostics Revenue (Pre-Q3 2022) | 1,427.9 | 1,500.9 |
Other Revenue | — | — |
Total Revenue | 2,813.4 | 2,755 |
| Revenue | LTM | Dec '24 |
|---|---|---|
Total Diagnostics Revenue (Pre-Q3 2022) | 1,427.9 | 1,500.9 |
Total Product Revenue | 2,309.8 | 2,338.2 |
Total Service Revenue | 503.6 | 416.8 |
Other Revenue | -1,427.9 | -1,500.9 |
Total Revenue | 2,813.4 | 2,755 |
| Revenue | LTM | Dec '24 |
|---|---|---|
Life Sciences Revenue (Pre-Q3 2022) | — | — |
Applied Markets Revenue (Pre-Q3 2022) | — | — |
Other Revenue | — | — |
Total Revenue | 2,813.4 | 2,755 |
| EBIT | LTM | Dec '24 |
|---|---|---|
Discovery & Analytical Solutions Operating Income (Pre-Q3 2022) | — | — |
Other EBIT | — | — |
Total EBIT | 363.6 | 346.7 |
| EBIT | LTM | Dec '24 |
|---|---|---|
Discovery & Analytical Solutions Operating Income (Post-Q2 2022) | 453.1 | 448 |
Diagnostics Operating Income (Pre-Q3 2022) | 351.2 | 373.2 |
Other EBIT | -440.7 | -474.5 |
Total EBIT | 363.6 | 346.7 |
| EBIT | LTM | Dec '24 |
|---|---|---|
Diagnostics Operating Income (Pre-Q3 2022) | 351.2 | 373.2 |
Other EBIT | 12.4 | -26.5 |
Total EBIT | 363.6 | 346.7 |